Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-818-9 | CAS number: 3621-82-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In the key study (Klimisch 1), 2,6-Dichlorobenzoxazol was tested for mutagenicity in two standard plate incorporation tests and in one preincubation test (each in the absence and in the presence of a metabolizing system) under GLP and according to OECD TG 471 (adopted 1997). In the main plate incorporation test, the substance was tested in bacteria strains TA 100, TA 1535, TA 1537 and TA 98 of S. thyphimurium and with E. Coli WP2uvrA at concentrations of50, 160, 500, 1600 and 5000μg/plate.Because of toxicity in the main plate incorporation test dose levels of 1.6, 5, 16, 50, 160 and 500 μg/plate(S. typhimurium tester strains) and dose levels of 5, 16, 50, 160, 500 and 1600μg/plate
(E. Coli WP2 uvrA) were chosen for the second plate incorporation test and the main preincubation test. For the repeat preincubation test dose levels from 1.6 to 500μg/plate were chosen in the absence of metabolic activation with the tester strain WP2 uvrA.Control plates without mutagen showed that the number of spontaneous revertant colonies was within the laboratory’s historical control range. All the positive controls showed the expected increase in the number of revertant colonies. There was no evidence of induced mutant colonies over background. In conclusion it can be stated that 2,6-Dichlorobenzoxazol is not mutagenic in this bacterial mutation test at any dose level either in the absence or presence of an exogenous metabolic activation system.
In an supporting standard Ames test (Klimisch 2) performed according to the former OECD TG 471 (adopted 1983) and under GLP 2,6-dichlorobenzoxazol was tested for mutagenicity in S. typhimurium strains TA 1535, TA 1537, TA 1538, TA 98 and TA 100 at six dose levels, in triplicate, both with and without metabolic activation. All positive control chemicals produced marked increases in the number of revertant colonies, both with and without metabolic activation and the activity of the S9 fraction was found to be satisfactory. The solvent (dimethylformamide) control plates gave counts of revertant colonies within the normal range. 2,6-Dichlorobenzoxazol caused a reduction in the growth of the bacterial lawn with all of the strains of salmonella tested both with and without metabolic activation. The most sensitive strains to the toxicity of 2,6-Dichlorobenzoxazol were TA 1535 and TA 1537 beginning at 500 µg/plate. 2,6-Dichlorobenzoxazol was, therefore, tested up to its toxic limit. A statistically significant increase in the number of revertant colonies wasrecorded in two of the three assays with and without S9. However, in one experiment with S9 the induction was below factor two, demonstrating that the statistical significance was not biologically signifcant. In all other cases, where the number of revertants was statistically signifcantly increased, the increase was below factor 3. Due to the lack of information about historical control data, a final conclusion about the biological relevance of the statistically significant increase cannot be drawn. Additionally, the TA 1538 strain is not listed as a tester strain in the current OECD TG. Therefore this observed effect can be regarded as ambigous.
In summary, 2,6 -Dichlorobenzoxazol was not mutagenic in all tester strains specified in the current OECD test guideline 471 with and without metabolic activation in both studies.
Short description of key information:
2,6 -Dichlorobenzoxazol was not mutagenic in tester strains
specified in the current OECD test guideline 471 with and without
metabolic activation in two Ames tests.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.